+ New Watchlist

Benzinga Research

-

-

-

-

-

-

-

Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

-

-

-

-

-

-

-

Comments

Loading...

Moleculin Biotech

MBRXNASDAQ

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$4.04

00.00%

Last update: 7:45 AM

15 minutes delayed

Moleculin Biotech (MBRX) Forecast

News

Earnings Guidance Dividends Analyst Ratings Insider Trades Short Interest

Latest news for Moleculin Biotech (NASDAQ:MBRX) Stock

Moleculin Biotech Stock (NASDAQ: MBRX)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Wednesday, July 10, 2024

Moleculin Biotech Completes End Of Phase 2 Me...
Benzinga Newsdesk

Friday, June 14, 2024

12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Moleculin Reports Additional Preliminary Inte...
Benzinga Newsdesk

Friday, June 07, 2024

Moleculin Biotech Files For Mixed Shelf Offer...
Benzinga Newsdesk

Wednesday, May 15, 2024

Moleculin Commences NIH-Funded Phase 2 Clinic...
Benzinga Newsdesk

Friday, May 10, 2024

Moleculin Biotech Q1 EPS $(2.02) Beats $(3.53...
Benzinga Newsdesk

Thursday, May 09, 2024

Moleculin Biotech Received Issue Notification...
Benzinga Newsdesk

Tuesday, May 07, 2024

Moleculin Reports Higher AML Complete Remissi...
Benzinga Newsdesk

Wednesday, May 01, 2024

Moleculin Announces Formation Of Scientific A...
Benzinga Newsdesk

Friday, April 26, 2024

12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights

Thursday, April 18, 2024

European Medicines Agency Grants Orphan Drug ...
Benzinga Newsdesk

Friday, April 12, 2024

Roth MKM Maintains Buy on Moleculin Biotech, ...
Benzinga Newsdesk

Wednesday, April 10, 2024

Moleculin Presents Data For Anthracycline
Benzinga Newsdesk

Monday, April 08, 2024

12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights

Wednesday, March 27, 2024

Moleculin Received U.S. Patent Issue Notifica...
Benzinga Newsdesk

Tuesday, March 26, 2024

Maxim Group Maintains Buy on Moleculin Biotec...
Benzinga Newsdesk

Monday, March 25, 2024

Moleculin Biotech shares are trading lower af...
Benzinga Newsdesk
Moleculin Biotech Provided A Preliminary Upda...
Benzinga Newsdesk

Friday, March 22, 2024

Moleculin Biotech FY23 EPS $(15.07) Vs $(15.2...
Benzinga Newsdesk
Trading Halt: Halt status updated at 8:55:00 ...
Benzinga Newsdesk
Earnings Scheduled For March 22, 2024
Benzinga Insights

Thursday, March 21, 2024

Trading Halt: Halted at 7:50:00 p.m. ET - Tra...
Benzinga Newsdesk
A Preview Of Moleculin Biotech's Earnings
Benzinga Insights

Wednesday, March 20, 2024

Micron, Signet Jewelers And 3 Stocks To Watch Heading Into Wednesday
Avi Kapoor

Tuesday, March 19, 2024

12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
Moleculin Biotech shares are trading higher. ...
Benzinga Newsdesk
Moleculin Announces 1-For-15 Reverse Stock Sp...
Benzinga Newsdesk

Monday, March 18, 2024

12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights

Monday, March 04, 2024

12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights

Wednesday, January 24, 2024

Moleculin Announces Year-End Annamycin Clinic...
Benzinga Newsdesk

Tuesday, January 23, 2024

12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights

Tuesday, January 16, 2024

12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights

Tuesday, January 09, 2024

12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights

Thursday, December 21, 2023

Moleculin Prices $4.5M Registered Direct Offe...
Benzinga Newsdesk

Thursday, December 14, 2023

HC Wainwright & Co. Initiates Coverage On Mol...
Benzinga Newsdesk

Monday, December 11, 2023

Moleculin Biotech Presents Interim Data From ...
Benzinga Newsdesk

Tuesday, November 21, 2023

12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights

Monday, November 13, 2023

Penny Stock Moleculin Highlights Interim Data From Blood Cancer Study With Complete Response Rate of 38%
Vandana Singh
Moleculin Provides Preliminary Update On Rece...
Benzinga Newsdesk
Moleculin Biotech Q3 EPS $(0.19) Vs $(0.30) P...
Benzinga Newsdesk
Earnings Scheduled For November 13, 2023
Benzinga Insights

Friday, November 10, 2023

Moleculin Biotech's Earnings: A Preview
Benzinga Insights

Monday, November 06, 2023

Moleculin Presents Preliminary Efficacy Findi...
Benzinga Newsdesk

Friday, November 03, 2023

On Nov 2, Moleculin Biotech Received Extensio...
Benzinga Newsdesk

Friday, October 20, 2023

12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights

Tuesday, October 17, 2023

12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights

Tuesday, October 10, 2023

12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights

Monday, October 02, 2023

Moleculin Doses First Subjects In Phase 2 Por...
Benzinga Newsdesk

Thursday, September 21, 2023

Moleculin Announces Completion Of Enrollment ...
Benzinga Newsdesk

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Prep
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2024 Benzinga | All Rights Reserved